- Home
- Catalog
- Growth hormone axis
- Sermorelin acetate
peptide · also known as GHRH 1-29
Sermorelin acetate
The 29-amino-acid N-terminal fragment of GHRH, as the acetate salt.
Sermorelin acetate · 10 mg · Lyophilised vial
peptide · also known as GHRH 1-29
Sermorelin acetate
The 29-amino-acid N-terminal fragment of GHRH, as the acetate salt.
In stock
What it is
Sermorelin is GHRH(1-29), the shortest fragment of growth-hormone-releasing hormone that retains full activity at the GHRH receptor. It has been used clinically as a diagnostic agent and is a reference compound in pituitary research.
Where it has been studied
- GHRH receptor pharmacology
- Growth hormone release and pulsatility
- Sleep and neuroendocrine studies
Selected literature
- Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocityKirk JM et al. · Clin Endocrinol (Oxf), 1994 · PMID 7955460
- Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing childrenBrain CE et al. · Clin Endocrinol (Oxf), 1990 · PMID 2140733
- The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiencyAchermann JC et al. · Eur J Endocrinol, 2000 · PMID 10754477
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
Specifications
| Compound | Sermorelin acetate (GHRH 1-29) |
|---|---|
| Type | Peptide |
| Selected presentation | 10 mg · Lyophilised vial |
| Form | Lyophilised powder in a sealed glass vial |
| Fill volume and concentration | Not applicable (lyophilised) |
| Label | CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only" |
| Storage | -20 °C for long-term storage; 2 to 8 °C for under three months; away from light |
| Certificate of analysis | Not yet published online. Request for a batch |
| Research areas | Growth hormone axis |
| All presentations | 10 mg lyophilised vial · € 78.00 |
Handling
- Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
- Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
- Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.





